Ocuphire Pharma Inc. Stock
Your prediction
Ocuphire Pharma Inc. Stock
There is an upward development for Ocuphire Pharma Inc. compared to yesterday, with an increase of €0.055 (2.750%).
Our community identified positive and negative aspects for Ocuphire Pharma Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Ocuphire Pharma Inc. stock. On the other hand our users think that "Innovation" could be a problem in the future.
Pros and Cons of Ocuphire Pharma Inc. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ocuphire Pharma Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ocuphire Pharma Inc. | 2.750% | 2.145% | 26.422% | 103.666% | 80.180% | -31.973% | - |
| NanoViricides Inc. | -3.670% | 4.808% | -12.097% | -21.583% | -27.333% | -9.693% | -61.888% |
| Actinium Pharmaceuticals Inc. | -1.790% | 4.739% | 16.334% | 10.708% | 11.381% | -87.590% | -86.784% |
| Immunic Inc. | 6.040% | -7.986% | -21.248% | -51.017% | -47.577% | -55.611% | -96.581% |
Comments
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its price target lowered by analysts at HC Wainwright from $20.00 to $18.00. They now have a "buy" rating on the stock.
Show more
Ratings data for OCUP provided by MarketBeat
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for OCUP provided by MarketBeat
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its price target lowered by analysts at Alliance Global Partners from $24.00 to $20.00. They now have a "buy" rating on the stock.
Show more
Ratings data for OCUP provided by MarketBeat
